Fate Therapeutics, Inc. (FATE)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 545.78M |
| Enterprise value | 218.89M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 5.59 |
| Price/book (mrq) | 1.13 |
| Enterprise value/revenue | 2.27 |
| Enterprise value/EBITDA | -0.71 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.52 |
| 52-week change 3 | -85.82% |
| S&P500 52-week change 3 | -13.21% |
| 52-week high 3 | 43.12 |
| 52-week low 3 | 4.02 |
| 50-day moving average 3 | 5.88 |
| 200-day moving average 3 | 18.71 |
Share statistics
| Avg vol (3-month) 3 | 4.12M |
| Avg vol (10-day) 3 | 4.05M |
| Shares outstanding 5 | 98.16M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 83.66M |
| % held by insiders 1 | 1.52% |
| % held by institutions 1 | 110.93% |
| Shares short (27 Feb 2023) 4 | 18.66M |
| Short ratio (27 Feb 2023) 4 | 7.37 |
| Short % of float (27 Feb 2023) 4 | 25.33% |
| Short % of shares outstanding (27 Feb 2023) 4 | 19.01% |
| Shares short (prior month 30 Jan 2023) 4 | 16.28M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 30 Dec 2022 |
Profitability
| Profit margin | -292.55% |
| Operating margin (ttm) | -320.23% |
Management effectiveness
| Return on assets (ttm) | -23.69% |
| Return on equity (ttm) | -48.46% |
Income statement
| Revenue (ttm) | 96.3M |
| Revenue per share (ttm) | 1.00 |
| Quarterly revenue growth (yoy) | 159.90% |
| Gross profit (ttm) | -224.15M |
| EBITDA | -294.63M |
| Net income avi to common (ttm) | -281.72M |
| Diluted EPS (ttm) | -2.73 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 436.23M |
| Total cash per share (mrq) | 4.44 |
| Total debt (mrq) | 109.34M |
| Total debt/equity (mrq) | 22.59 |
| Current ratio (mrq) | 4.40 |
| Book value per share (mrq) | 4.97 |
Cash flow statement
| Operating cash flow (ttm) | -248.21M |
| Levered free cash flow (ttm) | -148.77M |
© 2023 Yahoo. All rights reserved.
